Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment

Genome Medicine

Volumn 6, Issue 2, 2014, Pages

  Gustafsson, Mika ^a   Edström, Måns ^a   Gawel, Danuta ^a   Nestor, Colm E ^a   Wang, Hui ^a   Zhang, Huan ^a   Barrenäs, Fredrik ^a   Tojo, James ^b   Kockum, Ingrid ^b   Olsson, Tomas ^b   Serra Musach, Jordi ^c   Bonifaci, Núria ^c   Pujana, Miguel A ^c   Ernerudh, Jan ^a   Benson, Mikael ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CORTISONE; NATALIZUMAB;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL STUDY; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; HAY FEVER; HELPER CELL; HUMAN; HYPEREOSINOPHILIC SYNDROME; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; OVERLAPPING GENE; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LEUKEMIA; TRANSCRIPTOMICS; TRANSLATIONAL RESEARCH; ALLERGY; CELL DIFFERENTIATION; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN CELL;

EID: 84899648957     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm534     Document Type: Article

References (60)

1. Wang Z, Liao BY, Zhang J. Genomic patterns of pleiotropy and the evolution of complexity. Proc Natl Acad Sci USA 2010, 107:18034-18039. 10.1073/pnas.1004666107, 2964231, 20876104.
2. Albin RL. Antagonistic pleiotropy, mutation accumulation, and human genetic disease. Genetica 1993, 91:279-286. 10.1007/BF01436004, 8125276.
3. Brunner HG, van Driel MA. From syndrome families to functional genomics. Nat Rev Genet 2004, 5:545-551. 10.1038/nrg1383, 15211356.
4. Cotsapas C, Voight BF, Rossin E, Lage K, Neale BM, Wallace C, Abecasis GR, Barrett JC, Behrens T, Cho J, De Jager PL, Elder JT, Graham RR, Gregersen P, Klareskog L, Siminovitch KA, van Heel DA, Wijmenga C, Worthington J, Todd JA, Hafler DA, Rich SS, Daly MJ, FOCiS Network of Consortia Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011, 7:e1002254. 10.1371/journal.pgen.1002254, 3154137, 21852963, FOCiS Network of Consortia.
5. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. 10.1038/nature05911, 2719288, 17554300, Wellcome Trust Case Control Consortium.
6. Ramos PS, Criswell LA, Moser KL, Comeau ME, Williams AH, Pajewski NM, Chung SA, Graham RR, Zidovetzki R, Kelly JA, Kaufman KM, Jacob CO, Vyse TJ, Tsao BP, Kimberly RP, Gaffney PM, Alarcon-Riquelme ME, Harley JB, Langefeld CD, International Consortium on the Genetics of Systemic Erythematosus A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 2011, 7:e1002406. 10.1371/journal.pgen.1002406, 3234215, 22174698, International Consortium on the Genetics of Systemic Erythematosus.
7. Gutierrez-Achury J, Coutinho-de-Almeida R, Wijmenga C. Shared genetics in coeliac disease and other immune-mediated diseases. J Intern Med 2011, 269:591-603. 10.1111/j.1365-2796.2011.02375.x, 21401738.
8. Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: Common pathways with other diseases. Gut 2011, 60:1739-1753. 10.1136/gut.2009.199679, 21300624.
9. Feil R, Fraga MF. Epigenetics and the environment: Emerging patterns and implications. Nat Rev Genet 2012, 13:97-109.
10. Nestor CE, Barrenäs F, Wang H, Lentini A, Zhang H, Bruhn S, Jörnsten R, Langston MA, Rogers G, Gustafsson M, Benson M. DNA methylation changes separate allergic patients from healthy controls and may reflect altered CD4+ T-cell population structure. PLoS Genet 2014, 10:e1004059. 10.1371/journal.pgen.1004059, 3879208, 24391521.
11. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 2003, 114:323-334. 10.1016/S0092-8674(03)00570-1, 12914697.
12. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273. 10.1038/ng1180, 12808457.
13. Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, Assmann V, Elshamy WM, Rual JF, Levine D, Rozek LS, Gelman RS, Gunsalus KC, Greenberg RA, Sobhian B, Bertin N, Venkatesan K, Ayivi-Guedehoussou N, Sole X, Hernandez P, Lazaro C, Nathanson KL, Weber BL, Cusick ME, Hill DE, Offit K, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007, 39:1338-1349. 10.1038/ng.2007.2, 17922014.
14. Jonsson PF, Cavanna T, Zicha D, Bates PA. Cluster analysis of networks generated through homology: Automatic identification of important protein communities involved in cancer metastasis. BMC Bioinforma 2006, 7:2.
15. Segal E, Friedman N, Kaminski N, Regev A, Koller D. From signatures to models: Understanding cancer using microarrays. Nat Genet 2005, 37:S38-45. 10.1038/ng1561, 15920529.
16. Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A. Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions. Hum Mol Genet 2011, 20:3606-3619. 10.1093/hmg/ddr281, 21676896.
17. Wang IM, Zhang B, Yang X, Zhu J, Stepaniants S, Zhang C, Meng Q, Peters M, He Y, Ni C, Slipetz D, Crackower MA, Houshyar H, Tan CM, Asante-Appiah E, O'Neill G, Luo MJ, Thieringer R, Yuan J, Chiu CS, Lum PY, Lamb J, Boie Y, Wilkinson HA, Schadt EE, Dai H, Roberts C. Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol 2012, 8:594. 3421440, 22806142.
18. Huang E, Ishida S, Pittman J, Dressman H, Bild A, Kloos M, D'Amico M, Pestell RG, West M, Nevins JR. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet 2003, 34:226-230. 10.1038/ng1167, 12754511.
19. Zhou X, Wu W, Hu H, Milosevic J, Konishi K, Kaminski N, Wenzel SE. Genomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts. Am J Respir Cell Mol Biol 2011, 45:1256-1262. 10.1165/rcmb.2011-0065OC, 3262668, 21757679.
20. Bruhn S, Fang Y, Barrenas F, Gustafsson M, Zhang H, Konstantinell A, Kronke A, Sonnichsen B, Bresnick A, Dulyaninova N, Wang H, Zhao Y, Klingelhofer J, Ambartsumian N, Beck MK, Nestor C, Bona E, Xiang Z, Benson M. A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy. Sci Transl Med 2014, 6:218ra4. 10.1126/scitranslmed.3007410, 24401939.
21. Pe'er D, Hacohen N. Principles and strategies for developing network models in cancer. Cell 2011, 144:864-873. 10.1016/j.cell.2011.03.001, 3082135, 21414479.
22. McKinney EF, Lyons PA, Carr EJ, Hollis JL, Jayne DR, Willcocks LC, Koukoulaki M, Brazma A, Jovanovic V, Kemeny DM, Pollard AJ, Macary PA, Chaudhry AN, Smith KG. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010, 16:586-591. 1p following 591, 10.1038/nm.2130, 3504359, 20400961.
23. Wang H, Gottfries J, Barrenas F, Benson M. Identification of novel biomarkers in seasonal allergic rhinitis by combining proteomic, multivariate and pathway analysis. PLoS One 2011, 6:e23563. 10.1371/journal.pone.0023563, 3160968, 21887273.
24. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127. 10.1093/biostatistics/kxj037, 16632515.
25. Irizarry RA, Wang C, Zhou Y, Speed TP. Gene set enrichment analysis made simple. Stat Methods Med Res 2009, 18:565-575. 10.1177/0962280209351908, 3134237, 20048385.
26. Knijnenburg TA, Wessels LF, Reinders MJ, Shmulevich I. Fewer permutations, more accurate P-values. Bioinformatics 2009, 25:i161-8. 10.1093/bioinformatics/btp211, 2687965, 19477983.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc 1995, 57:289-300.
28. Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, Gandhi TK, Chandrika KN, Deshpande N, Suresh S, Rashmi BP, Shanker K, Padma N, Niranjan V, Harsha HC, Talreja N, Vrushabendra BM, Ramya MA, Yatish AJ, Joy M, Shivashankar HN, Kavitha MP, Menezes M, Choudhury DR, Ghosh N, Saravana R, Chandran S, Mohan S, Jonnalagadda CK, Prasad CK, et al. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 2004, 32:D497-501. 10.1093/nar/gkh070, 308804, 14681466.
29. Milacic M, Haw R, Rothfels K, Wu G, Croft D, Hermjakob H, D'Eustachio P, Stein L. Annotating cancer variants and anti-cancer therapeutics in reactome. Cancers (Basel) 2012, 4:1180-1211. 10.3390/cancers4041180, 3712731, 24213504.
30. Yu H, Tardivo L, Tam S, Weiner E, Gebreab F, Fan C, Svrzikapa N, Hirozane-Kishikawa T, Rietman E, Yang X, Sahalie J, Salehi-Ashtiani K, Hao T, Cusick ME, Hill DE, Roth FP, Braun P, Vidal M. Next-generation sequencing to generate interactome datasets. Nat Methods 2011, 8:478-480. 10.1038/nmeth.1597, 3188388, 21516116.
31. CCSB Interactome Database. [http://interactome.dfci.harvard.edu/].
32. Wang X, Wei X, Thijssen B, Das J, Lipkin SM, Yu H. Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol 2012, 30:159-164. 10.1038/nbt.2106, 3708476, 22252508.
33. Kanehisa M. Molecular network analysis of diseases and drugs in KEGG. Methods Mol Biol 2013, 939:263-275. 10.1007/978-1-62703-107-3_17, 23192552.
34. Ingenuity Pathway Analyses (IPA). [http://www.ingenuity.com/].
35. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29. 10.1038/75556, 3037419, 10802651.
36. Mammalian Phenotype database. [ftp.informatics.jax.org/pub/reports/index.html].
37. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, Greninger P, Thompson IR, Luo X, Soares J, Liu Q, Iorio F, Surdez D, Chen L, Milano RJ, Bignell GR, Tam AT, Davies H, Stevenson JA, Barthorpe S, Lutz SR, Kogera F, Lawrence K, McLaren-Douglas A, Mitropoulos X, Mironenko T, Thi H, Richardson L, Zhou W, Jewitt F, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012, 483:570-575. 10.1038/nature11005, 3349233, 22460902.
38. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15. 10.1093/nar/gng015, 150247, 12582260.
39. Barrenas F, Chavali S, Alves AC, Coin L, Jarvelin MR, Jornsten R, Langston MA, Ramasamy A, Rogers G, Wang H, Benson M. Highly interconnected genes in disease-specific networks are enriched for disease-associated polymorphisms. Genome Biol 2012, 13:R46-2012. 13-6-r46, 10.1186/gb-2012-13-6-r46, 3446318, 22703998.
40. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C. The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011, 39:D561-568. 10.1093/nar/gkq973, 3013807, 21045058.
41. Zhao Y, Wang H, Gustafsson M, Muraro A, Bruhn S, Benson M. Combined multivariate and pathway analyses show that allergen-induced gene expression changes in CD4+ T cells are reversed by glucocorticoids. PLoS One 2012, 7:e39016. 10.1371/journal.pone.0039016, 3373548, 22701743.
42. Wang H, Barrenas F, Bruhn S, Mobini R, Benson M. Increased IFN-gamma activity in seasonal allergic rhinitis is decreased by corticosteroid treatment. J Allergy Clin Immunol 2009, 124:1360-1362. 10.1016/j.jaci.2009.09.037, 19910031.
43. Benson M, Langston MA, Adner M, Andersson B, Torinssson-Naluai A, Cardell LO. A network-based analysis of the late-phase reaction of the skin. J Allergy Clin Immunol 2006, 118:220-225. 10.1016/j.jaci.2006.03.006, 16815159.
44. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009, 106:9362-9367. 10.1073/pnas.0903103106, 2687147, 19474294.
45. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010, 20:4-12. 10.1038/cr.2009.138, 3494736, 20010916.
46. Engelbertsen D, Andersson L, Ljungcrantz I, Wigren M, Hedblad B, Nilsson J, Bjorkbacka H. T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol 2013, 33:637-644. 10.1161/ATVBAHA.112.300871, 23307873.
47. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. The central role of CD4(+) T cells in the antitumor immune response. J Exp Med 1998, 188:2357-2368. 10.1084/jem.188.12.2357, 2212434, 9858522.
48. Cheng X, Wang J, Xia N, Yan XX, Tang TT, Chen H, Zhang HJ, Liu J, Kong W, Sjoberg S, Folco E, Libby P, Liao YH, Shi GP. A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation. EMBO Mol Med 2012, 4:1112-1125. 10.1002/emmm.201201272, 3491840, 23027613.
49. Palleja A, Horn H, Eliasson S, Jensen LJ. DistiLD Database: Diseases and traits in linkage disequilibrium blocks. Nucleic Acids Res 2012, 40:D1036-1040. 10.1093/nar/gkr899, 3245128, 22058129.
50. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teague JW, Campbell PJ, Stratton MR, Futreal PA. COSMIC: Mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011, 39:D945-950. 10.1093/nar/gkq929, 3013785, 20952405.
51. Online Mendelian Inheritance in Man. [http://omim.org/].
52. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2 Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219. 10.1038/nature10251, 3182531, 21833088, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2.
53. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. DrugBank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011, 39:D1035-1041. 10.1093/nar/gkq1126, 3013709, 21059682.
54. Sugaya N, Kanai S, Furuya T. Dr. PIAS 2.0: An update of a database of predicted druggable protein-protein interactions. Database (Oxford 2012, 2012:bas034. 3468816, 23060433.
55. Mittelbrunn M, Molina A, Escribese MM, Yanez-Mo M, Escudero E, Ursa A, Tejedor R, Mampaso F, Sanchez-Madrid F. VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses. Proc Natl Acad Sci USA 2004, 101:11058-11063. 10.1073/pnas.0307927101, 503740, 15263094.
56. Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. J Neuroimmunol 2008, 194:153-164. 10.1016/j.jneuroim.2007.11.007, 18178259.
57. Wagner GP, Zhang J. The pleiotropic structure of the genotype-phenotype map: The evolvability of complex organisms. Nat Rev Genet 2011, 12:204-213.
58. Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z. GATA3: A multispecific but potentially useful marker in surgical pathology: A systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 2013, 13:22.
59. Teoh H, Quan A, Creighton AK, Annie Bang KW, Singh KK, Shukla PC, Gupta N, Pan Y, Lovren F, Leong-Poi H, Al-Omran M, Verma S. BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis. Gene Ther 2013, 20:51-61. 10.1038/gt.2011.214, 22257935.
60. Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J, Agusti A, Brightling C, Cambon-Thomsen A, Cesario A, Abdelhak S, Antonarakis SE, Avignon A, Ballabio A, Baraldi E, Baranov A, Bieber T, Bockaert J, Brahmachari S, Brambilla C, Bringer J, Dauzat M, Ernberg I, Fabbri L, Froguel P, Galas D, Gojobori T, Hunter P, Jorgensen C, Kauffmann F, et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 2011, 3:43. 10.1186/gm259, 3221551, 21745417.